Zebra-Med’s AI1 “all in one” bundle will be available on the Nuance AI Marketplace to support functions dedicated to radiology

November 25, 2019 — Zebra Medical Vision announced that its AI1 “all-in-one” bundle of artificial intelligence (AI) products will be available on the Nuance AI Marketplace. Nuance offers the first and largest portal with one-stop access to a wide range of AI diagnostic models.

The Nuance AI Marketplace functions like an app store that is dedicated to radiology. It provides algorithm developers consolidated, at-scale access to users of Nuance PowerScribe, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 6,500 connected healthcare facilities. Radiologists can discover, test, and use algorithms from within their familiar PowerScribe workflows, to increase reporting efficiency and quality, as well as help healthcare teams improve patient outcomes and healthcare costs. A built-in feedback channel lets users share real-world results with developers for algorithm refinement, and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing algorithm usage, costs and performance.

As part of the Nuance AI Marketplace, Zebra Medical Vision will provide its AI1 “all-in-one” bundle, including access to an ever-growing number of AI solutions, integrated into radiologist workflow at an affordable, fixed annual fee. The company’s AI solutions analyze millions of clinical imaging in real time, detecting various medical indications, and alerting the relevant stakeholders in hospitals and clinics.

Zebra-Med’s AI1 introduced the new “all-in-one” bundle with a growing portfolio of AI solutions. The AI1 2020 version offers a wide range of products in three categories with the highest medical impact and patient outcome. The bundle will be launched at the upcoming RSNA conference, and will include some of the following solutions:

● Stat.AI: A multi-modality AI triage solution for the head CT package, in order to identify suspected intracranial hemorrhage (ICH), and a chest X-ray package for identifying suspected pneumothorax. Both products are FDA cleared and CE marked.

● Oncology: Breast Cancer package with an automatic AI Triage mammography solution that indicates “suspicious” versus “non suspicious” for usage in diagnostic 2-D mammography. The mammo CAD solution is CE marked and the Triage solution is currently for investigational use only.

“We are thrilled that our software will now be available on the Nuance AI Marketplace,” said John LoGioco, CCO of Zebra Medical Vision. “This collaboration will give us maximum exposure on one of the largest and most reputable portals, with one-stop access to a wide range of AI diagnostic models. Our work with Nuance will enable Zebra-Med’s products to impact the health of many more patients, through the industry’s most widely used radiology reporting platform.”

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images